HomeYB3 • FRA
add
Shin Nippon Biomedical Laboratories Ltd
Previous close
€9.55
Day range
€9.30 - €9.30
Year range
€6.25 - €11.50
Market cap
64.57B JPY
P/E ratio
-
Dividend yield
-
Primary exchange
TYO
Market news
Financials
Income Statement
Revenue
Net income
| (JPY) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 9.73B | 59.46% |
Operating expense | 3.35B | 11.61% |
Net income | 1.87B | 126.39% |
Net profit margin | 19.27 | 42.00% |
Earnings per share | — | — |
EBITDA | 2.28B | 289.24% |
Effective tax rate | 18.01% | — |
Balance Sheet
Total assets
Total liabilities
| (JPY) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 10.06B | -22.65% |
Total assets | 97.30B | 36.33% |
Total liabilities | 52.21B | 26.96% |
Total equity | 45.09B | — |
Shares outstanding | 41.63M | — |
Price to book | 0.01 | — |
Return on assets | 4.87% | — |
Return on capital | 6.02% | — |
Cash Flow
Net change in cash
| (JPY) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 1.87B | 126.39% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1957
Website
Employees
1,457
